CoChat
Sign Up
Cited by 38

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges

Maruszewska-Cheruiyot, M., Donskow-Łysoniewska, K., Doligalska, M.·2018·Helminthologia
DOI 10.1515/helm-2017-0048PMC PMC6799527
Open this paper in CoChat — free account

Abstract

Summary: Development of modern medicine and better living conditions in the 20th century helped in reducing a number of cases of infectious diseases. During the same time, expansion of autoimmunological disorders was noticed. Among other are Inflammatory Bowel Diseases (IBD) including ulcerative colitis and Crohn’s disease which are chronic and relapsing inflammation of the gastrointestinal tract. Absence of effective treatment in standard therapies effects the search for alternative opportunities. As per hygienic hypothesis increasing number of cases of autoimmune diseases is as a result of reduced exposure to pathogens, especially parasites. Thus, one of the promising remedial acts against IBD and other allergic and autoimmune disorders is “helminth therapy”. Cure with helminths seems to be the most effective therapy of IBD currently proposed. Helminth therapy focuses on advantageous results that have been obtained from the clinical trials, but its mechanisms are still unclear. Explanation of this phenomenon would help to develop new drugs against IBD based on helminth immunomodulatory molecules.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/helm-2017-0048

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 86

  1. Adisakwattana, P., Nuamtanong, S., Kusolsuk, T., Chairoj, M., Yenchitsomanas, P.T., Chaisri, U. (2013): Non-encapsulated Trichinella spp., T. papuae, diminishes severity of DSS-induced colitis in mice. Asian Pac. J. Allergy Immunol., 31: 106 – 114. DOI: 10.12932/AP0238.31.2.201310.12932/AP0238.31.2.2013 · DOI
  2. Barthlott, T., Kassiotis, G., Stockinger, B. (2003): T cell regulation as a side effect of homeostasis and competition. J. Exp. Med., 197: 451 – 460. doi: 10.1084/jem.2002138710.1084/jem.20021387 · DOI
  3. Bernstein, R.M. (2001): Injections and surgical therapy in chronic pain. Clin. J. Pain., 17: 94 – 10410.1097/00002508-200112001-00018 · DOI
  4. Biedermann, L., Zeitz, J., Mwinyi, J., Sutter-Minder, E., Rehman, A., Ott, S. J., Steurer-Stey, C., Frei, A., Frei, P., Scharl, M., Loessner, M. J., Vavricka, S. R., Fried, M., Schreiber, S., Schuppler, M., Rogler, G. (2013) : Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One, 8: e59260. DOI: 10.1371/journal.pone.0059260 · DOI
  5. Bilbo, S.D., Wray, G.A., Perkins, S.E., Parker, W. (2011): Reconstitution of the human biome as the most reasonable solution for epidemics of allergic and autoimmune diseases. Med. Hypotheses., 77: 494 – 504. DOI: 10.1016/j.mehy.2011.06.01910.1016/j.mehy.2011.06.019 · DOI
  6. Blum, A.M., Hang, L., Setiawan, T.,. Urban, J.P., Stoyanoff, K.M., Leung, J., Weinstock, J.V. (2012): Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J. Immunol., 189 (5): 2512 – 2520. DOI: 10.4049/jimmunol.110289210.4049/jimmunol.1102892 · DOI
  7. Bodammer, P., Waitz, G., Loebermann, M., Holtfreter, M.C., Maletzki, C., Krueger, M.R., Nizze, H., Emmrich, J., Reisinger, E.C. (2011): Schistosoma mansoni infection but not egg antigen promotes recovery from colitis in outbred NMRI mice. Dig. Dis. Sci., 56: 70 – 78. DOI: 10.1007/s10620-010-1237-y10.1007/s10620-010-1237-y · DOI
  8. Brandtzaeg, P., Haraldsen, G., Rugtveit, J. (1997): Immunopathology of human inflammatory bowel disease. Springer Semin. Immunopathol., 18: 555 – 589. DOI: 10.1007/BF0082405810.1007/BF00824058 · DOI
  9. Broadhurst, M.J., Ardeshir, A., Kanwar, B., Mirpuri, J., Gundra, U.M., Leung, J.M., Wiens, K.E., Vujkovic-Cvijin, I., Kim, C.C., Yarovinsky, F., Lerche, N.W., McCune, J.M., Loke, P. (2012): Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog., 8: e1003000. DOI: 10.1371/journal.ppat.1003000 · DOI
  10. Cader, M.Z., Kaser, A. (2013): Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut, 62: 1653 – 1664. DOI: 10.1136/gutjnl-2012-30395510.1136/gutjnl-2012-303955 · DOI
  11. Chandrashekara, S. (2012): The treatment strategies of autoimmune disease may need a different approach from conventional protocol: A review. Indian J. Pharmacol., 44: 665 – 671. DOI: 10.4103/0253-7613.10323510.4103/0253-7613.103235 · DOI
  12. Chassaing, B., Aitken, J.D., Malleshappa, M., Vijay-Kumar, M. (2015): Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol., 104: 15 – 25. DOI: 10.1002/0471142735.im1525s10410.1002/0471142735.im1525s104 · DOI
  13. Chen, C.C., Louie, S., McCormick, B., Walker, W.A., Shi, H.N. (2005): Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect. Immun., 73: 5468 – 5481. DOI: 10.1128/IAI.73.9.5468-5481.200510.1128/IAI.73.9.5468-5481.2005 · DOI
  14. Chen, C.C., Louie, S., McCormick, B.A., Walker, W.A., Shi, H.N. (2006): Helminth primed dendritic cells alter the host response to enteric bacterial infection. J. Immunol.,176: 472 – 483 · DOI
  15. Cleynen, I., Boucher, G., Jostins, L. et al. (2016): Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet, 9, 156 – 167. DOI: 10.1016/S0140-6736(15)00465-110.1016/S0140-6736(15)00465-1 · DOI
  16. Correale, J. (2014): Helminth/Parasite treatment of multiple sclerosis. Curr. Treat Options Neurol.,16: 296. DOI: 10.1007/s11940-014-0296-310.1007/s11940-014-0296-3 · DOI
  17. Croese, J., Giacomin, P., Navarro, S., Clouston, A., McCann, L., Dougall, A., Ferreira, I., Susianto, A., O’Rourke, P., Howlett, M., McCarthy, J., Engwerda, C., Jones, D., Loukas, A. (2015): Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J. Allergy Clin. Immunol.,135: 508 – 516. DOI: 10.1016/j.jaci.2014.07.02210.1016/j.jaci.2014.07.022 · DOI
  18. Croese, J., O’neil, J., Masson, J., Cooke, S., Melrose, W., Pritchard, D., Speare, R. (2006): A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors. Gut, 55: 136 – 137. doi: 10.1136/gut.2005.07912910.1136/gut.2005.079129 · DOI
  19. Daveson, A.J., Jones, D.M., Gaze, S., McSorley, H., Clouston, A., Pascoe, A., Cooke, S., Speare, R., Macdonald, G.A., Anderson, R., McCarthy, J.S., Loukas, A., Croese, J. (2011): Effect of hookworm infection on wheat challenge in celiac disease – a randomised double-blinded placebo controlled trial. PLoS One, 8: e17366. DOI: 10.1371/journal.pone.0017366 · DOI · Paper page
  20. Donskow, K., Drela, N., Doligalska, M. (2011): Heligmosomoides bakeri antigen rescues CD4-positive T cells from glucocorticoid-induced apoptosis by Bcl-2 protein expression. Parasite Immunol., 33: 158 – 169. DOI: 10.1111/j.1365-3024.2010.01262.x10.1111/j.1365-3024.2010.01262.x · DOI
  21. Donskow-Łysoniewska, K., Bien, J., Brodaczewska, K., Krawczak, K., Doligalska, M. (2013b): Colitis promotes adaptation of an intestinal nematode: a Heligmosomoides polygyrus mouse model system. PLoS One, 22: e78034. DOI: 10.1371/journal.pone.0078034 · DOI
  22. Donskow-Łysoniewska, K., Brodaczewska, K., Doligalska, M. (2013a): Heligmosomoides polygyrus antigens inhibit the intrinsic pathway of apoptosis by overexpression of survivin and Bcl-2 protein in CD4 T cells. Prion, 7: 319 – 327. DOI:10.4161/pri.2500810.4161/pri.25008 · DOI
  23. Donskow-Lysoniewska, K., Majewski, P., Brodaczewska, K., Jozwicka, K., Doligalska, M. (2012): Heligmosmoides polygyrus fourth stages induce protection against DSS induced colitis and change opioid expression in the intestine. Parasite Immunol., 34: 536 – 546. DOI: 10.1111/pim.1200310.1111/pim.12003 · DOI
  24. Du, L., Tang, H., Ma, Z., Xu, J., Gao, W., Chen, J., Gan, W., Zhang, Z., Yu, X., Zhou, X., Hu, X. (2011): The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice. Dig. Dis. Sci., 56: 2810 – 2817. DOI: 10.1007/s10620-011-1689-810.1007/s10620-011-1689-8 · DOI
  25. Elliott, D.E., Li, J., Blum, A., Metwali, A., Qadir, K., Urban, J.F. Jr, Weinstock, J.V. (2003): Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol., 284: G385 – G391. DOI: 10.1152/ajpgi.00049.200210.1152/ajpgi.00049.2002 · DOI
  26. Elliott, D.E., Setiawan, T., Metwali, A., Blum, A., Urban, J.F. Jr., Weinstock, J.V. (2004): Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur. J. Immunol., 34: 2690 – 2698. DOI: 10.1002/eji.200324833 · DOI
  27. Elliott, D.E., Urban, J.F. Jr., Argo, C.K., Weinstock, J.V. (2000): Does the failure to acquire helminthic parasites predispose to Crohn’s disease? FASEB J., 14: 1848 – 1855. doi: 10.1096/fj.99-0885hyp10.1096/fj.99-0885hyp · DOI
  28. Erb, K.J. (2009): Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases? Trends Immunol., 30: 75 – 82. DOI: 10.1016/j.it.2008.11.00510.1016/j.it.2008.11.005 · DOI
  29. Finlay, C.M., Walsh, K.P., Mills, K.H. (2014): Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol. Rev., 259: 206 – 230. DOI: 10.1111/imr.1216410.1111/imr.12164 · DOI
  30. Fleming, J.O., Isaak, A., Lee, J.E., Luzzio, C.C., Carrithers, M.D., Cook, T.D., Field, A.S., Boland, J., Fabry, Z. (2011): Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult. Scler., 17: 743 – 754. DOI: 10.1177/135245851139805410.1177/1352458511398054 · DOI
  31. Goodridge, H.S., Stepek, G., Harnett, W., Harnett, M.M. (2005): Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62. Immunology, 115: 296 – 304. DOI: 10.1111/j.1365-2567.2005.02167.x10.1111/j.1365-2567.2005.02167.x · DOI
  32. Gouy De Bellocq, J., Ferte, H., Depaquit, J., Justine, J.L., Tillier, A., Durette-Desset, M.C. (2001): Phylogeny of the Trichostrongylina (Nematoda) inferred from 28S rDNA sequences. Mol. Phylogenet. Evol., 19: 430 – 442. DOI: 10.1006/mpev.2001.092510.1006/mpev.2001.0925 · DOI
  33. Hadis, U., Wahl, B., Schulz, O., Hardtke-Wolenski, M., Schippers, A., Wagner, N., Müller, W., Sparwasser, T., Förster, R., Pabst, O. (2011): Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity, 34: 237 – 246. DOI: 10.1016/j.immuni.2011.01.01610.1016/j.immuni.2011.01.016 · DOI
  34. Hang, L., Setiawan, T., Blum, A.M., Urban, J., Stoyanoff, K., Arihiro, S., Reinecker, H.C., Weinstock, J.V. (2010): Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J. Immunol, 185: 3184 – 3189. DOI: 10.4049/jimmunol.100094110.4049/jimmunol.1000941 · DOI
  35. Helmby, H. (2015): Human helminth therapy to treat inflammatory disorders - where do we stand? BMC Immunol., 16: 12. DOI: 10.1186/s12865-015-0074-310.1186/s12865-015-0074-3 · DOI
  36. Herrera, L.A., Ostrosky-Wegman, P. (2001): Do helminths play a role in carcinogenesis? Trends Parasitol., 17: 172 – 175. DOI: 10.1016/S1471-4922(00)01942-510.1016/S1471-4922(00)01942-5 · DOI
  37. Hokke, C.H., Deelder, A.M., Hoffmann, K.F., Wuhrer, M. (2007): Glycomics-driven discoveries in schistosome research. Exp. Parasitol., 117: 275 – 283. DOI: 10.1016/j.exppara.2007.06.00310.1016/j.exppara.2007.06.003 · DOI
  38. Hunter, M.M., Wang, A., Hirota, C.L., Mckay, D.M. (2005): Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J. Immunol., 174: 7368 – 7375. DOI: 10.4049/jimmunol.174.11.7368 · DOI
  39. Hunter, M.M., Wang, A., Mckay, D.M. (2007): Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology, 132: 1320 – 1330. DOI: 10.1053/j.gastro.2007.01.03810.1053/j.gastro.2007.01.038 · DOI
  40. Ince, M.N., Elliott, D.E., Setiawan, T., Metwali, A., Blum, A., Chen, H.L., Urban, J.F., Flavell, R.A., Weinstock, J.V. (2009): Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. J. Immunol., 39: 1870 – 1878. DOI: 10.1002/eji.20083895610.1002/eji.200838956 · DOI
  41. Kappus, K.D., Lundgren, R.G. Jr., Juranek, D.D., Roberts, J.M., Spencer, H.C. (1994): Intestinal parasitism in the United States: update on a continuing problem. Am. J. Trop. Med. Hyg., 50, 705 – 713. DOI: 10.4269/ajtmh.1994.50.70510.4269/ajtmh.1994.50.705 · DOI
  42. Keubler, L.M., Buettner, M., Häger, C., Bleich, A. (2015): A multihit model: colitis lessons from the Interleukin-10-deficient mouse. Inflamm. Bowel Dis., 2: 1967 – 1975. DOI: 10.1097/MIB.0000000000000468 · DOI
  43. Khan, A.R., Fallon, P.G. (2013): Helminth therapies: translating the unknown unknowns to known knowns. Int. J. Parasitol., 43: 293 – 299. DOI: 10.1016/j.ijpara.2012.12.00210.1016/j.ijpara.2012.12.002 · DOI
  44. Khan, W.I., Blennerhasset, P.A., Varghese, A.K., Chowdhury, S.K., Omsted, P., Deng, Y., Collins, S.M. (2002): Intestinal nematode infection ameliorates experimental colitis in mice. Infect. Immun., 70: 5931 – 5937. doi: 10.1128/IAI.70.11.5931-5937.200210.1128/IAI.70.11.5931-5937.2002 · DOI
  45. Lakatos, P.L. (2006): Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J. Gastroenterol., 14: 6102-6108. doi: 10.3748/wjg.v12.i38.610210.3748/wjg.v12.i38.6102 · DOI
  46. Leitner, G.C., Vogelsang, H. (2016): Pharmacological-and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J. Gastrointest. Pharmacol. Ther., 6: 5 – 20. DOI: 10.4292/wjgpt.v7.i1.510.4292/wjgpt.v7.i1.5 · DOI
  47. Leong, R.W., Mitrev, N., Ko, Y. (2016): Hygiene hypothesis: Is the evidence the same all over the world? Dig. Dis., 34: 35 – 42. DOI: 10.1159/00044292210.1159/000442922 · DOI
  48. Leung, J., Hang, L., Blum, A., Setiawan, T., Stoyanoff, K., Weinstock, J. (2012): Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease. Inflamm. Bowel Dis., 18: 1447 – 1455. DOI: 10.1002/ibd.2285810.1002/ibd.22858 · DOI
  49. Li, X., Sundquist, J., Hemminki, K., Sundquist, K. (2011): Risk of inflammatory bowel disease in firstand second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm. Bowel Dis., 17: 1784 – 1791. DOI: 10.1002/ibd.2153510.1002/ibd.21535 · DOI
  50. MacDonald, T.T., Monteleone, G. (2005): Immunity, inflammation, and allergy in the gut. Science, 25: 1920 – 1925. DOI: 10.1126/science.110644210.1126/.1106442 · DOI
  51. Maizels, R.M., Balic, A., Gomez-Escobar, N., Nair, M., Taylor, M.D., Allen, J.E. (2004): Helminth parasites – masters of regulation. Immunol. Rev., 201, 89 – 116. DOI: 10.1111/j.0105-2896.2004.00191.x10.1111/j.0105-2896.2004.00191.x · DOI
  52. Maizels, R.M., Hewitson, J.P., Smith, K.A. (2012): Susceptibility and immunity to helminth parasites. Curr. Opin. Immunol., 24: 459 – 466. DOI: 10.1016/j.coi.2012.06.00310.1016/j.coi.2012.06.003 · DOI
  53. Mann, E.R., Li, X. (2014): Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol., 7: 9653 – 9664. DOI: 10.3748/wjg.v20.i29.965310.3748/wjg.v20.i29.9653 · DOI
  54. McGuckin, M.A., Eri, R., Simms, L.A., Florin, T.H., Radford-Smith, G. (2009): Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis., 15: 100 – 113. DOI: 10.1002/ibd.2053910.1002/ibd.20539 · DOI
  55. McSorley, H.J., Hewitson, J.P., Maizels, R.M. (2013): Immunomodulation by helminth parasites: defining mechanisms and mediators. Int. J. Parasitol., 43: 301 – 310. DOI: 10.1016/j.ijpara.2012.11.01110.1016/j.ijpara.2012.11.011 · DOI
  56. Melon, A., Wang, A., Phan, V., Mckay, D.M. (2010): Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice. J. Biomed. Biotechnol., 384523. DOI: 10.1155/2010/38452310.1155/2010/384523 · DOI
  57. Metwali, A., Setiawan, T., Blum, A.M., Urban, J., Elliott, D.E., Hang, L., Weinstock, J.V. (2006): Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am. J. Physiol. Gastrointest. Liver Physiol., 291: G253 – G259. DOI: 10.1152/ajpgi.00409.2005 · DOI
  58. Molodecky, N.A., Soon, I.S., Rabi, D.M., Ghali, W.A., Ferris, M., Chernoff, G., Benchimol, E.I., Panaccione, R., Ghosh, S., Barkema, H.W., Kaplan, G.G. (2012): Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142: 46 – 54. DOI: 10.1053/j.gastro.2011.10.00110.1053/j.gastro.2011.10.001 · DOI
  59. Monroy, F.G., Enriquez, F.J. (1992): Heligmosomoides polygyrus: a model for chronic gastrointestinal helminthiasis. Parasitol. Today, 8: 49 – 54. DOI: 10.1016/0169-4758(92)90084-F10.1016/0169-4758(92)90084- · DOI
  60. Morampudi, V., Bhinder, G., Wu, X., Dai, C., Sham, H.P., Vallance, B.A., Jacobson, K. (2014): DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat. J. Vis. Exp., 84: 51297. DOI:10.3791/51297 · DOI
  61. Moreels, T.G., Nieuwendijk, R.J., De Man, J.G., De Winter, B.Y., Herman, A.G., Van Marck, E.A., Pelckmans, P.A. (2004): Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut, 53: 99 – 107 · DOI
  62. Mulvenna, J., Hamilton, B., Nagaraj, S.H., Smyth, D., Loukas, A., Gorman, J.J. (2009): Proteomics analysis of the excretory/secretory component of the blood-feeding stage of the hookworm, Ancylostoma caninum. Mol. Cell. Proteomics, 8: 109 – 121. DOI: 10.1074/mcp.M800206-MCP200 · DOI
  63. Niewiadomski, O., Studd, C., Wilson, J., Williams, J., Hair, C., Knight, R., Prewett, E., Dabkowski, P., Alexander, S., Allen, B., Dowling, D., Connell, W., Desmond, P., Bell, S. (2016): Influence of food and lifestyle on the risk of developing inflammatory bowel disease. Intern. Med. J., 46: 669 – 676. DOI: 10.1111/imj.1309410.1111/imj.13094 · DOI
  64. Packham, G., Stevenson, F.K. (2005): Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology, 114: 441 – 449. DOI: 10.1111/j.1365-2567.2005.02117.x10.1111/j.1365-2567.2005.02117.x · DOI
  65. Prasanphanich, N.S., Mickum, M.L., Heimburg-Molinaro, J., Cummings, R.D. (2013): Glycoconjugates in host-helminth interactions. Front. Immunol., 4: 240. DOI: 10.3389/fimmu.2013.0024010.3389/fimmu.2013.00240 · DOI
  66. Probert, C.S., Jayanthi, V., Pinder, D., Wicks, A.C., Mayberry, J.F. (1992): Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut, 33: 687 – 69310.1136/gut.33.5.687 · DOI
  67. Reardon, C., Sanchez, A., Hogaboam, C.M., Mckay, D.M. (2001): Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium induced colitis. Infect. Immun., 69: 4417 – 4423. doi: 10.1128/IAI.69.7.4417-4423.200110.1128/IAI.69.7.4417-4423.2001 · DOI
  68. Rescigno, M., Di Sabatino, A. (2009): Dendritic cells in intestinal homeostasis and disease. J. Clin. Invest.,119: 2441 – 2450. DOI: 10.1172/JCI3913410.1172/JCI39134 · DOI
  69. Ruyssers, N.E., De Winter, B.Y., De Man, J.G., Loukas, A., Herman, A.G., Pelckmans, P.A., Moreels, T.G. (2008): Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin. Dev. Immunol., 567314. DOI: 10.1155/2008/567314 · DOI
  70. Sandborn, W.J., Elliott, D.E., Weinstock, J., Summers, R.W., Landry-Wheeler, A., Silver, N., Harnett, M.D., Hanauer, S.B. (2013): Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn’s disease. Aliment. Pharmacol. Ther., 38: 255 – 263. DOI: 10.1111/apt.1236610.1111/apt.12366 · DOI
  71. Satsangi, J., Silverberg, M.S., Vermeire, S., Colombel, J.F. (2006): The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 55: 749 – 753. DOI: 10.1136/gut.2005.08290910.1136/gut.2005.082909 · DOI
  72. Schnoeller, C., Rausch, S., Pillai, S., Avagyan, A., Wittig, B. M., Loddenkemper, C., Hamann, A., Hamelmann, E., Lucius, R., Hartmann, S. (2008): A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J. Immunol., 15: 4265 – 4272. DOI: 10.4049/jimmunol.180.6.4265 · DOI
  73. Setiawan, T., Metwali, A., Blum, A.M. Nedim Ince, M., Urban Jr., J.F., Elliott, D.E., Weinstock, J.V. (2007): Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect. Immun., 75: 4655 – 4663. DOI: 10.1128/IAI.00358-0710.1128/IAI.00358-07 · DOI
  74. Shorter, R.G., Huizenga, K.A., Spencer, R.J. (1972): A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am. J. Dig. Dis., 17: 1024 – 103210.1007/BF02239143 · DOI
  75. Smith, P., Mangan, N.E., Fallon, P.G. (2009): Generation of parasite antigens for use in Toll-like receptor research. Methods Mol., 517: 401 – 413. DOI: 10.1007/978-1-59745-541-1_2410.1007/978-1-59745-541-1_24 · DOI
  76. Smith, P., Mangan, N.E., Walsh, C.M., Fallon, R.E., Mckenzie, A.N.J., Van Rooijen, N., Fallon, P.G. (2007): Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J. Immunol., 178: 4557 – 4566. DOI: 10.4049/jimmunol.178.7.455710.4049/jimmunol.178.7.4557 · DOI
  77. Strachan, D.P. (1989): Hay fever, hygiene and household size. BMJ, 299: 1259 – 1260 · DOI · Paper page
  78. Summers, R.W., Elliott, D.E., Qadir, K., Urban, J.F., Thompson, R., Weinstock, J.V. (2003): Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol., 98, 2034 – 2041. DOI: 10.1111/j.1572-0241.2003.07660.x10.1111/j.1572-0241.2003.07660.x · DOI
  79. Summers, R.W., Elliott, D.E., Urban, J.F. Jr., Thompson, R., Weinstock, J.V. (2005a): Trichuris suis therapy in Crohn’s disease. Gut, 54: 87 – 90. DOI: 10.1136/gut.2004.04174910.1136/gut.2004.041749 · DOI
  80. Summers, R.W., Elliott, D.E., Urban, J.F. Jr., Thompson, R.A., Weinstock, J.V. (2005b): Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology, 128: 825 – 832. DOI: 10.1053/j.gastro.2005.01.00510.1053/j.gastro.2005.01.005 · DOI
  81. Sutton, T.L., Zhao, A., Madden, K.B., Elfrey, J.E., Tuft, B.A., Sullivan, C.A., Urban, Jr., J.F., Shea-Donohue, T. (2008): Antiinflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model. Infect. Immun., 76: 4772 – 4782. DOI: 10.1128/IAI.00744-0710.1128/IAI.00744-07 · DOI
  82. Taylor, M.D., Van Der Werf, N., Maizels, R.M. (2012): T cells in helminth infection: the regulators and the regulated. Trends Immunol., 33: 181 – 189. DOI: 10.1016/j.it.2012.01.00110.1016/j.it.2012.01.001 · DOI
  83. Wilson, M.S., Maizels, R.M. (2004): Regulation of allergy and autoimmunity in helminth infection. Clin. Rev. Allergy Immunol., 26: 35 – 50. DOI: 10.1385/CRIAI:26:1:3510.1385/CRIAI:26:1:35 · DOI
  84. Wirtz, S., Neurath, M.F. (2007): Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev., 59: 1073 – 1083. DOI: 10.1016/j.addr.2007.07.00310.1016/j.addr.2007.07.003 · DOI
  85. Xia, C.M., Zhao, Y., Jiang, L., Jiang, J., Zhang, S.C. (2011): Schistosoma japonicum ova maintains epithelial barrier function during experimental colitis. World J Gastroenterol., 17: 4810 – 4816.10.3748/wjg.v17.i43.4810 · DOI
  86. Zhao, Y., Zhang, S., Jiang, L., Jiang, J., Liu, H. (2009): Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice. J. Gastroenterol. Hepatol., 24: 1775 – 1780. DOI: 10.1111/j.1440-1746.2009.05986.x10.1111/j.1440-1746.2009.05986.x · DOI

Cited by

Sorted by citations

See all 38

Metadata

Authors
Maruszewska-Cheruiyot, M., Donskow-Łysoniewska, K., & Doligalska, M.
Venue
Helminthologia
Publisher
Walter de Gruyter GmbH
Published
2018-01-27
Volume
55
Issue
1
Pages
1-11
ISSN
  • 1336-9083
  • 0440-6605
DOI
10.1515/helm-2017-0048
PMC
PMC6799527
Cited by
38
References
1
Language
en
Licence
creativecommons.org/licenses/by-nc-nd/3.0 (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges. https://app.cochat.ai/papers/10.1515/helm-2017-0048
The paper
Maruszewska-Cheruiyot, M., Donskow-Łysoniewska, K., & Doligalska, M. (2018). Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges. Helminthologia. https://doi.org/10.1515/helm-2017-0048